Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.

Publication Year: 2022

DOI:
10.1002/ijc.34223

PMCID:
PMC9804595

PMID:
35866293

Journal Information

Full Title: Int J Cancer

Abbreviation: Int J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no potential conflicts of interest."

Evidence found in paper:

"Funding information Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/T007974/1; National Institutes of Health, NIH, Grant/Award Number: R01 HL133932‐01; Science for Life Laboratory; Swedish Research Council Formas, Grant/Award Numbers: VR 2017‐00650, 222‐2014‐1341; UK Dementia Research Institute, Grant/Award Number: UKDRI‐5001"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025